clarithromycin has been researched along with Carcinoma, Large Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamada, K; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S; Tsujimoto, M | 1 |
Fukuoka, K; Hamada, K; Kataoka, T; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Segawa, K; Teramoto, S; Tsujimoto, M; Ueda, K | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S; Tsujimoto, M; Ueta, K | 1 |
1 trial(s) available for clarithromycin and Carcinoma, Large Cell
Article | Year |
---|---|
[Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer].
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-6; Lung Neoplasms; Male; Middle Aged | 1998 |
2 other study(ies) available for clarithromycin and Carcinoma, Large Cell
Article | Year |
---|---|
[Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration].
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-12; Lung Neoplasms; Male; RNA, Messenger | 1997 |
[Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Middle Aged; Survival Rate | 1997 |